In a shot in the arm for the FTSE 100 group, a trial revealed that Imfinzi showed promise in treating highly aggressive small cell lung cancer.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.